Subscribe
Healthcare

FDA panel recommends new COVID-19 vaccines, which could be available as early as September

By Gabrielle M. Etzel
Published
Add Washington Examiner on Google
FDA panel recommends new COVID-19 vaccines, which could be available as early as September

A Food and Drug Administration advisory panel voted unanimously on Thursday to issue an updated COVID-19 vaccine for the remainder of 2023 and early 2024, to be available as early as September.

Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.

Tag:

Centers for Disease Control and Prevention COVID-19 FDA Pfizer